Indole-2-carboxamides as novel NR2B selective NMDA receptor antagonists

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 21, 2003, Pages 3859-3861

  Borza, István ^a   Kolok, Sándor ^a   Gere, Anikó ^a   Ágai Csongor, Éva ^a   Ágai, Béla ^b   Tárkányi, Gábor ^a   Horváth, Csilla ^a   Barta Szalai, Gizella ^a   Bozó, Éva ^a   Kiss, Csilla ^a   Bielik, Attila ^a   Nagy, József ^a   Farkas, Sándor ^a   Domány, György ^a  

^a GEDEON RICHTER LTD   (Hungary)

^b BUDAPEST UNIVERSITY OF TECHNOLOGY AND ECONOMICS   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

1 [2 HYDROXY 3 (4 HYDROXYPHENYL)PROPYL] 4 (4 METHYLBENZYL)PIPERIDIN 4 OL; 4 BENZYL ALPHA (4 HYDROXYPHENYL) BETA METHYL 1 PIPERIDINEPROPANOL; 6 [2 [4 (4 FLUOROBENZYL)PIPERIDIN 1 YL]ETHANESULFINYL] 3H BENZOXAZOL 2 ONE; AMIDE; CI 1041; HYDROXYL GROUP; INDOLE 2 CARBOXAMIDE DERIVATIVE; INDOLE DERIVATIVE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PIPERIDINE DERIVATIVE; PROTEIN SUBUNIT; UNCLASSIFIED DRUG;

ARTICLE; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME SYNTHESIS; IC 50; STRUCTURE ACTIVITY RELATION; SUBSTITUTION REACTION;

EID: 12444275570     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(03)00708-X     Document Type: Article

References (15)

1. Chenard B.L., Menniti F.S. Curr. Pharm. Des. 5:1999;381.
2. Nikam S.S., Meltzer L. Curr. Pharm. Des. 8:2002;845.
3. Thompson, W.; Claremon, D. A.; Munson, P. M.; Whitter, W.; Kulagowski, J.; Huscroft, I. PCT Int. Appl. WO200132615-A1. 2001;
4. Chem. Abstr. 2001, 134, 340510.
5. Fischer G., Mutel V., Traube G., Malherbe P., Kew J.N.C., Mohacsi E., Heitz M.P., Kemp J.A. J. Pharmacol. Exp. Ther. 283:1997;1285.
6. Wright, J. L.; Kesten, S. R.; Upasani, R. B.; Lan, N. C. PCT Int. Appl. WO2000000197-A1. 2000;
7. Chem. Abstr. 2000, 132, 64255.
8. Tamiz A.P., Cai S.X., Zhou Z., Yuen P., Schelkun R.M., Whittemore E.R., Weber E., Woodward R.M., Keana J.F.W. J. Med. Chem. 42:1999;3412.
9. 13C NMR and MS spectra for all intermediates and final compounds were consistent with the assigned structures. All final compounds gave satisfactory C, H and N analyses.
10. Mutel V., Buchy D., Klingelschmidt A., Messer J., Bleuel Z., Kemp J.A., Richards J.G. J. Neurochem. 70:1998;2147.
11. Richards, J. G.; Messer, J.; Buchy, D.; Klingelschimdt, A.; Mutel, V. Br. J. Pharmacol. 1997, 120 (Proc. Suppl, 39P).
12. Nagy J., Boros A., Dezsõ P., Kolok S., Fodor L. Neurochem. Int. 43:2003;19.
13. Wermuth C.G. Wermuth C.G. The Practice of Medicinal Chemistry. 1996;228 Academic, London, San Diego, New York, Boston, Sydney, Tokyo, Toronto.
14. Kondo K., Morohoshi S., Mitsuhashi M., Murakami Y. Chem. Pharm. Bull. 47:1999;1227.
15. Boger D.L., Cerbone L.R., Yohannes D. J. Org. Chem. 53:1988;5163.